home icon user icon
Welcome to International Network for Natural Sciences | INNS Pub.
Home My Account
Submit Manuscript
double_slash
breadcumb_bg

Impact of physical factors on Covid-19: A four months statistical study for designing Covid-19 chambers and isolation centers

Paper Details

Research Paper 01/08/2020
Views (448) Download (33)
current_issue_feature_image
publication_file

Impact of physical factors on Covid-19: A four months statistical study for designing Covid-19 chambers and isolation centers

Hafiz Muhammad Asmar Naeem, Muhammad Faizan Khurram Maqsood, Muhammad Sufyan Khalid, Areeb Yousaf, Faiqa Afzal, Muhammad Ahsan jamil, Qandeel-e-Arsh, Muhammad Adil Shabir, Behroz Zafar, Nimra Asad
Int. J. Biosci.17( 2), 97-107, August 2020.
Certificate: IJB 2020 [Generate Certificate]
Key: COVID-19COVID-19 ChambersIsolation centresSARS-CoV-2Statistical Study

Abstract

SARS-CoV-2 is a deadly virus that has locked down the whole universe and still prevailing at a very rapid rate. As of 11th 2020, the reported confirmed cases of SARS-CoV-2 count reached 4,006,257 around the world, and it reported 278,892 deaths globally. There is no specific vaccination or other cure available until now. SARS-CoV-2 is highly sensitive to abiotic factors. The viral structure is strongly affected by temperature, Relative Humidity and UV Index. In our review, we studied the impact of abiotic factors on SARS-CoV-2 by using regression and correlation statistical analysis.  These analyses helped out in finding that the countries with comparatively high temperature, Relative Humidity and UV Index are at lower risk of the pandemic and vice versa. The death ratio is also lower in countries with higher values of abiotic factors. Therefore, it is suggested to design specific “COVID-19” chambers with adjustable figures of three discussed abiotic factors and, on the same bases, isolation centers could be adjusted accordingly. The temperature of 38°C, the relative humidity of >95% and UV radiation of 254nm assisted with the airflow is optimized for lowering the activity of SARS-CoV-2 keeping in view the bearable amounts for human bodies. However, these values could be altered according to the condition of the patients.

VIEWS 43
Cover PDF

Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, Evans L. 2020. Covid-19 in critically ill patients in the Seattle region—case series. New England Journal of Medicine 382(21), 2012-2022.

Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. 2020. Features, evaluation and treatment coronavirus (COVID-19) StatPearls [Internet]: StatPearls Publishing.

Chan JFW, Kok KH, Zhu Z, Chu H, To KK.-W., Yuan S, Yuen KY. 2020. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging microbes & infections, 9(1), 221-236.

Chan KH, Peiris JSM, Lam SY, Poon LLM, Yuen KY, Seto WH. The Effects of Temperature and Relative Humidity on the Viability of the SARS Coronavirus. https://doi.org/10.1155/2011/734690

Currie D. 2012. National Public Health Week celebrated nationwide: Health departments, schools, communities hold events. The Nation’s Health, 42(5), 18-31.

Darnell MER, Subbarao K, Feinstone SM, Taylor DR. 2004. Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV. Journal of Virological Methods 121(1), 85-91. https://doi.org/10.1016/j.jviromet.2004.06.006

Du L, Yang Y, Zhou Y, Lu L, Li F, Jiang S. 2017. MERS-CoV spike protein: a key target for antivirals. Expert opinion on therapeutic targets 21(2), 131-143.

Gorbalenya A, Baker S, Baric R, de Groot R, Drosten C, Gulyaeva A, Neuman B. 2020. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology.

Gralinski LE, Menachery VD. 2020. Return of the Coronavirus: 2019-nCoV. Viruses 12(2), 135.

Grossoehme NE, Li L, Keane SC, Liu P, Dann III CE, Leibowitz JL, Giedroc DP. 2009. Coronavirus N protein N-terminal domain (NTD) specifically binds the transcriptional regulatory sequence (TRS) and melts TRS-cTRS RNA duplexes. Journal of molecular biology 394(3), 544-557.

Khan S, Siddique R, Ali A, Bai Q, Li Z, Li H,. Nabi G. 2020. The spread of novel coronavirus has created an alarming situation worldwide. Journal of infection and public health.

Letko MC, Munster V. 2020. Functional assessment of cell entry and receptor usage for lineage B β-coronaviruses, including 2019-nCoV. bioRxiv.

Menachery VD, Yount Jr, BL, Debbink K, Agnihothram S, Gralinski LE, Plante JA, Donaldson EF. 2015. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nature medicine 21(12), 1508.

Organization WH. 2020a. Coronavirus disease 2019 (‎ COVID-19)‎: situation report, 92.

Organization WH. 2020b. Coronavirus disease 2019 (COVID-19): situation report, 72.

Raymondos K, Molitoris U, Capewell M, Sander B, Dieck T, Ahrens J, Corrado A. 2012. Negative- versus positive-pressure ventilation in intubated patients with acute respiratory distress syndrome. Critical Care 16(2), R37. https://doi.org/10.1186/cc11216

Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. 2020. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. Journal of Advanced Research.

Tang B, Bragazzi NL, Li Q, Tang S, Xiao Y, Wu J. 2020. An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov). Infectious disease modelling 5, 248-255.

Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. 2020. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Peng Z. 2020. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA, 323(11), 1061-1069. https://doi.org/10.1001/jama.2020.1585

Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Pei YY. 2020. A new coronavirus associated with human respiratory disease in China. Nature, 579(7798), 265-269.

Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, Zhou Y. 2020. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. International Journal of Infectious Diseases.

Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Huang CL. 2020. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798), 270-273.

Zhou Y, Yang Y, Huang J, Jiang S, Du L. 2019. Advances in MERS-CoV vaccines and therapeutics based on the receptor-binding domain. Viruses, 11(1), 60.

Submit Manuscript